Patient Guide: A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 21 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06421636
Status: 🟢 Enrolling Now
Condition: Non-Transfusion Dependent Beta-Thalassemia (NTDT)
Phase: PHASE2

Where You Can Participate

This study is available at 21 locations across the country.

Top locations include:
  • • New York, New York
  • • Tbilisi,
  • • Tbilisi,
  • • And 18 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body - Join Clinical Trial NCTNCT06421636

How to Join This Clinical Trial - NCTNCT06421636

Learn how to participate in this PHASE2 trial studying an investigational therapy for Non-Transfusion Dependent Beta-Thalassemia (NTDT). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-Transfusion Dependent Beta-Thalassemia (NTDT). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-Transfusion Dependent Beta-Thalassemia (NTDT)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06421636 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 21 locations. Find a study site near you:

Clinical Research Site

New York, New York 10065 - United States

Status: RECRUITING

Clinical Research Site

Tbilisi, 0159 - Georgia

Status: RECRUITING

Clinical Research Site

Tbilisi, 0160 - Georgia

Status: RECRUITING

Clinical Research Site

New Delhi, Delhi 110029 - India

Status: RECRUITING

Clinical Research Site

Ahmedabad, Gujarat 380009 - India

Status: RECRUITING

Clinical Research Site

Surat, Gujarat 395002 - India

Status: RECRUITING

Clinical Research Site

Kochi, Kerala 682041 - India

Status: RECRUITING

Clinical Research Site

Mumbai, Maharashtra 400022 - India

Status: RECRUITING

Clinical Research Site

Jaipur, Rajasthan 302004 - India

Status: RECRUITING

Clinical Research Site

Delhi, 110048 - India

Status: RECRUITING

And 11 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Non-Transfusion Dependent Beta-Thalassemia (NTDT):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships